InMed Pharmaceuticals Added to CSE25 Index

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announces that InMed has been included in the CSE25 Index. InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index.

Maricann Revises Convertible Debenture Terms

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF) announces that it has amended the terms of its previously announced private placement of convertible debenture units.

InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

CFN Media Group announces the publication of an article covering how InMed Pharmaceuticals Inc. (CSE: IN) (CNSX: IN) (IN.CN) (OTCQB: IMLFF) is leveraging biosynthesis to solve a major problem in the medical cannabis industry as it adds key ex-Eli Lilly personnel to its efforts.